Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization -September 26, 2023 at 01:02 am EDT

PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 26 September 2023, 07:00 CEST BIOCARTIS ANNOUNCES H1 2023 RESULTS AND PROVIDES AN UPDATE ON THE OPERATIONAL REORGANIZATION AND...

Related Keywords

Japan ,United Kingdom ,Belgium ,United States ,Mechelen ,Region Flamande ,Japanese ,Belgian ,America ,Deloitte Bedrijfsrevisoren Reviseurs ,Herman Verrelst ,Jean Marc Roelandt ,Nico Houthaeve ,Skylinedx Merlin ,George Cardoza ,Piet Houwen ,Nichirei Biosciences ,Roger Moody ,Biocartis Group ,Twitter ,Shareholders Of Biocartis Group ,Corporate Communications Investor Relations Biocartis ,Exchange Commission ,Assay Technologies Ltd ,Biocartis Us Inc ,Drug Administration ,Company Or Biocartis ,Ministry Of Health ,Neither The Company ,Head Of Service Delivery ,Bonds ,European Union ,Euronext Brussels ,Interim Financial Reporting ,Chief Executive Officer ,Balance Sheet Restructuring ,New Biocartis ,Second Ranking Secured Convertible Bonds ,Equity Injection ,Service Delivery ,Medical Advisory Board ,Assay Kit ,Breast Cancer Subtyping ,Thyroidprint Assay ,Polymerase Chain Reaction ,United States Securities ,Markets ,